Patents by Inventor Ralph Hall

Ralph Hall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel compounds
    Publication number: 20060211727
    Abstract: Novel substituted 1,5,7-trisubstituted-1,8-napthyridin-2(1H)-one compounds; 1,5,7 trisubstituted-1,6-napthyridine-2-(1H)-one compounds and 1,5,7-trisubstituted quinoline-2(1H)-one compounds, processes for the preparation thereof, the use thereof in treating CSBP/p38 kinase mediated diseases and pharmaceutical compositions for use in such therapy.
    Type: Application
    Filed: February 13, 2004
    Publication date: September 21, 2006
    Inventors: Jeffrey Boehm, James Callahan, Ralph Hall, Xichen Lin, Katherine Widdowson
  • 3,4-dihydro-(1H)quinazolin-2-one compounds as CSBP/p38 kinase inhibitors
    Patent number: 7053099
    Abstract: Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Grant
    Filed: November 21, 2000
    Date of Patent: May 30, 2006
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Michael J. Bower, Ralph Hall, Don Edgar Griswold, David C. Underwood
  • Protease inhibitors
    Publication number: 20060052365
    Abstract: This invention relates 4-amino-azepan-3-ones of formula (I) which are useful as protease inhibitors, particularly of cathepsin S, and as such are useful for preventing a number of diseases amongst which are atherosclerotic lesions and pulmonary diseases such as asthma and allergic reactions.
    Type: Application
    Filed: August 22, 2003
    Publication date: March 9, 2006
    Inventors: William Bondinell, Ralph Hall, Qi Jin, Jeffrey Kerns, Hong Nie, Katherine Widdowson
  • Novel Compounds
    Publication number: 20050203109
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: August 19, 2003
    Publication date: September 15, 2005
    Inventors: Jerry Adams, Jeffrey Boehm, Ralph Hall, Qi Jin, Jiri Kasparec, Domingos Silva, John Taggart
  • 3,4-Dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
    Publication number: 20050075352
    Abstract: Novel substituted quinazoline compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: July 2, 2004
    Publication date: April 7, 2005
    Inventors: Jerry Adams, Michael Bower, Ralph Hall, Don Griswold, David Underwood
  • Novel compounds
    Publication number: 20040209901
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: April 6, 2004
    Publication date: October 21, 2004
    Applicant: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Jeffrey C. Boehm, Ralph Hall, Qi Jin, Jiri Kasparec, Domingos J. Silva, John J. Taggart
  • 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
    Patent number: 6759410
    Abstract: The present invention relates to 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolines of formula (1), or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
    Type: Grant
    Filed: May 10, 2002
    Date of Patent: July 6, 2004
    Assignee: SmithLine Beecham Corporation
    Inventors: Jerry L. Adams, Michael J. Bower, Ralph Hall, Don Edgar Griswold, David C. Underwood
  • Novel compounds
    Publication number: 20040116697
    Abstract: Novel substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy as CSBP/p38 kinase inhibitors.
    Type: Application
    Filed: April 18, 2003
    Publication date: June 17, 2004
    Inventors: Jerry L. Adams, Jeffrey C. Boehm, Ralph Hall, Qi Jin, Jiri Kasparec, Domingos J. Silva, John J. Taggart
  • Feedforward amplifiers
    Patent number: 4130807
    Abstract: In a feedforward amplifier the balance of the error cancelling loop can be controlled in amplitude and phase by a variable resistor and a variable capacitor connected to the input to the auxiliary amplifier. This can (a) be used for remotely controlled amplifiers to maximize the effect of phase scatter of third order intermodulation vectors, or (b) in a terminal to introduce deliberate distortion to cancel distortion introduced in line amplifiers.
    Type: Grant
    Filed: June 24, 1977
    Date of Patent: December 19, 1978
    Assignee: International Standard Electric Corporation
    Inventors: Ralph A. Hall, Peter E. Radley